Literature DB >> 2467186

Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer.

T M Browder1, J S Abrams, P M Wong, A W Nienhuis.   

Abstract

Endogenous expression of the interleukin-3 (IL3) gene introduced with a retrovirus vector renders hematopoietic cells autonomous of exogenous growth factor. To investigate the mechanism of autocrine stimulation, 25 clones were isolated after retrovirus transduction of IL3 into 32D-cl23 or FDC-P1 cells. Medium conditioned by these autonomous IL3-producing clones supported the growth of factor-dependent 32D cells. Although there was a severalfold variation in the amount of IL3 secreted (some clones secreted barely detectable levels), the doubling time of each clone in the absence of added IL3 was identical to that of the parental cell line maximally stimulated by exogenous IL3. Concentrated monoclonal and polyclonal antibodies, both highly effective in neutralizing exogenous IL3, were assayed for ability to inhibit autocrine growth. Minimal inhibitory effects were observed only on washed autocrine clones secreting low levels of IL3. To test the activity of cytoplasmically synthesized IL3, the nucleotides encoding the signal sequence of IL3 were deleted and replaced with an in-frame ATG in the context of a consensus translation initiation sequence. Ten 32D clones expressing this restructured IL3 genome were obtained. Despite the presence of biologically active IL3 in cell lysates, all clones remained dependent on exogenous IL3, with the same dose-response as that found for 32D cells. Our data are most compatible with a mechanism whereby endogenously produced IL3 interacts with its receptor prior to surface display.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467186      PMCID: PMC362162          DOI: 10.1128/mcb.9.1.204-213.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells.

Authors:  J W Schrader; R M Crapper
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

3.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

4.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

Authors:  T Yokota; F Lee; D Rennick; C Hall; N Arai; T Mosmann; G Nabel; H Cantor; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.

Authors:  J N Ihle; J Keller; S Oroszlan; L E Henderson; T D Copeland; F Fitch; M B Prystowsky; E Goldwasser; J W Schrader; E Palaszynski; M Dy; B Lebel
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

6.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells.

Authors:  M Jaye; R M Lyall; R Mudd; J Schlessinger; N Sarver
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  14 in total

1.  Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.

Authors:  I Seif; E De Maeyer; I Riviere; J De Maeyer-Guignard
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 2.  Hematopoietic stem and progenitor cell signaling in the niche.

Authors:  Stephanie N Hurwitz; Seul K Jung; Peter Kurre
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

3.  High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library.

Authors:  B Y Wong; H Chen; S W Chung; P M Wong
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Rates of mutation to growth factor autonomy and tumorigenicity differ in hematopoietic stem and precursor cells expressing the multilineage colony-stimulating factor gene.

Authors:  C Laker; N Kluge; C Stocking; U Just; M J Franz; W Ostertag; J F DeLamarter; M Dexter; E Spooncer
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

Authors:  M Roth; M Nauck; M Tamm; A P Perruchoud; R Ziesche; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 6.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

Review 7.  Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.

Authors:  A Yayon; M Klagsbrun
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

8.  Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.

Authors:  B Barut; D Chauhan; H Uchiyama; K C Anderson
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 9.  The role of VEGF in normal and neoplastic hematopoiesis.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

10.  Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.

Authors:  Y Levy; A Tsapis; J C Brouet
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.